about
Complement receptor is an inhibitor of the complement cascadeComplement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosusTissue-specific autoantibodies in haemolytic anaemiaC3b inactivator in the rheumatic diseases. Measurement by radial immunodiffusion and by inhibition of formation of properdin pathway C3 convertase.Isolation of lymphocyte membrane complement receptor type two (the C3d receptor) and preparation of receptor-specific antibodyImmunologic diagnosis and monitoring of human acute leukemias: a review.Third component of human complement: localization of the internal thiolester bond.Release of soluble immune complexes from immune adherence receptors on human erythrocytes is mediated by C3b inactivator independently of Beta 1H and is accompanied by generation of C3c.The sequential appearance of Ia-like antigens and two different complement receptors during the maturation of human neutrophils.Release of endogenous C3b inactivator from lymphocytes in response to triggering membrane receptors for beta 1H globulinMembrane distribution and adsorptive endocytosis by C3b receptors on human polymorphonuclear leukocytes.Identification of a C3bi-specific membrane complement receptor that is expressed on lymphocytes, monocytes, neutrophils, and erythrocytes.Anaphylatoxin-mediated regulation of the immune response. I. C3a-mediated suppression of human and murine humoral immune responses.Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes.Generation of three different fragments of bound C3 with purified factor I or serum. II. Location of binding sites in the C3 fragments for factors B and H, complement receptors, and bovine conglutinin.Studies on the mechanism of phagocytosis. II. The interaction of macrophages with anti-immunoglobulin IgG-coated bone marrow-derived lymphocytes.Evidence for presence of an internal thiolester bond in third component of human complement.Surface marker and other characteristics of Gaucher's cells.Surface markers of complement receptor lymphocytesA subpopulation of normal human peripheral B lymphcytes that bind IgEQuantitative influence of antibody and complement coating of red cells on monocyte-mediated cell lysisgp140, the C3d receptor of human B lymphocytes, is also the Epstein-Barr virus receptor.Subpopulations of human lymphoblastoid cell lines. Correlation with the expression of surface receptors and content of Epstein-Barr virus genome.Antiserums for immunofluorescent enumeration of human T lymphocytes utilizing fluoresceinated staphylococcal protein A.Complement receptors and cell associated complement components.Tissue localization of complement component 3 receptor-bearing cells in lymphoid tissue after injection with complete Freund adjuvant.Membrane receptors on neutrophils.Identification of mononuclear cells in situ in skin lesions of lichen planus.Human lymphocyte complement receptors. Quantitative requirements for C3 of normal and chronic lymphocyte leukemia lymphocytes.Lymphocyte subpopulations in man: relationship between four subpopulations identified by membrane markers.Relationships between C3b receptor (CR1) activity of erythrocytes and positive Coombs' tests.Complement receptor subtypes C3b and C3d in lymphatic tissue and follicular lymphomaBinding of fluid-phase complement components C3 and C3b to human lymphocytes.Complement bridges between cells analysis of a possible cell-cell interaction mechanism.The binding of human complement proteins C5, factor B, beta 1H and properdin to complement fragment C3b on zymosan.Complement receptors in human renal glomeruli.Receptors on guinea-pig erythrocytes specific for cell-bound fourth component of human complement (C4).Effect of complement on the viscoelastic properties of human erythrocyte membrane.
P2860
Q24302183-ACE1AB85-261C-453F-9394-1B3EE04EF4B3Q24302256-F8718003-9A21-42C2-9F56-ECFA3F1B05FAQ34860425-5B538AB7-B2E4-4648-98FB-B13D755AB798Q35201919-46AF11C9-B551-4F5D-BA8B-0C6903A18E5CQ35332704-3625573C-F26A-4DB2-B699-410E2C291425Q35864034-45B8D0B5-2144-4EF6-B672-15469F670CE5Q36281685-F8E295A8-F1F4-460B-A146-DD12612A0E51Q36308579-521F564A-8271-4A03-91A7-C7D767B7835DQ36339977-42146ABB-19AE-4124-A4BD-9A990C225208Q36344262-34F22B46-C784-4535-BD42-F05562D42401Q36344873-3215FAEB-FC3F-4C0C-AADA-348783A57451Q36346014-F714A40F-FDED-4C34-865A-3767D7017B17Q36346514-F0FE0B1C-5DD7-410B-9479-13DB6DD902CAQ36347257-6CC8ED9B-269A-4BDE-8696-9A86F9483FE9Q36348883-E904E4E2-8ACB-4D9C-BC46-31E02DD694B8Q36359863-BB875D6B-7A9B-4098-8FE6-5F9572C2A7C2Q36409419-D13DAE59-C228-48A0-8D0A-B79BBF1B8140Q36614685-DE1FAA0C-7D61-4FE4-AF62-4DFB62012E85Q37033486-DA4396FA-3146-4039-8FD9-F40BD593012EQ37043727-130BD1BF-241E-41CC-A27D-39F191C152E5Q37053730-3C494DD6-95B6-4A83-A850-3761CFFDB6D0Q37679591-DA651DB8-130E-454C-AF22-351B27D7E138Q39406186-9278967F-06DA-4CDF-927C-B508B16A3CA3Q39616803-76212276-26FA-4BB8-BB9D-6D4B606846B5Q39623007-90BCC52A-4CEE-4F6C-B996-E29EBE8106ADQ40599155-45685D08-910D-4C3E-A139-02808B9D8A82Q40652742-4DE90228-AABC-41F6-B825-52A04DDC7F59Q40685154-03294EA0-C661-47F1-B630-8BAE07325673Q40691549-E26F5C69-306B-449A-98C2-ADB511FCBDE8Q41072237-70A5C292-8393-493B-933C-AE2FB9FC7A0DQ41153227-3A0DECD5-87A1-4DEE-910C-42D68F09DB70Q41458456-1ADD0F6F-E32D-46CF-9BE4-1355C29C8AC3Q41817272-7EF1C3B2-7333-46C2-9C3E-713EB1393627Q42929526-3A4B1DEB-0AB3-47C8-BC9D-C31AB1D6BC01Q43830771-45D13382-34DB-4FAF-BA75-974BB8ED8D20Q44148131-C39FDCE0-F419-4633-AAF9-7FF50E47364AQ46943188-8EE24679-4515-424D-A2C7-2848058CC91FQ53768299-A1CC1A48-3555-46F0-907E-D64C9670ABFF
P2860
description
1975 nî lūn-bûn
@nan
1975年の論文
@ja
1975年論文
@yue
1975年論文
@zh-hant
1975年論文
@zh-hk
1975年論文
@zh-mo
1975年論文
@zh-tw
1975年论文
@wuu
1975年论文
@zh
1975年论文
@zh-cn
name
Specificity of human lymphocyte complement receptors.
@en
type
label
Specificity of human lymphocyte complement receptors.
@en
prefLabel
Specificity of human lymphocyte complement receptors.
@en
P2860
P356
P1476
Specificity of human lymphocyte complement receptors.
@en
P2093
P2860
P304
P356
10.1084/JEM.141.5.1163
P407
P577
1975-05-01T00:00:00Z